VEGFC and carcinoma: Over-expression of VEGF-C has been observed in several carcinomas, such as lung carcinomas, head and neck cancers, breast carcinomas, prostate carcinoma, colon carcinomas, gastric cancers, and papillary thyroid carcinomas [11–17].